Voliotis Dimitris
SVP, Clinical Development at ZNTL
- Sold, on record
- $1.9M
- Dollars the filings state
- Form 4 sales
- 2
- Latest Feb 14, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ZNTLZentalis Pharmaceuticals, Inc.SVP, Clinical Development
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ZNTLUnusualJan 20 2022
Sold 30,000 shares at $61.36 ($1.8M)
Voliotis Dimitris, SVP, Clinical Development
Sold 82.8% of holdings ($2.2M position)6,250 shares leftFirst sale on recordFiling
- 2 Form 4 sale ZNTLPlan not statedFeb 14 +25 days
Sold 601 shares at $50.23 ($30k)
Voliotis Dimitris, SVP, Clinical Development
Sold 3.6% of holdings ($833k position)15,978 shares leftFiling
Every transaction
Loading transactions…